or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    GILD A Gilead Sciences, Inc. 0.95
    GALT C Galectin Therapeutics Inc. 0.00
    ALNY C Alnylam Pharmaceuticals, Inc. -1.63
    GNFT C GENFIT S.A. 1.63
    BLTE C Belite Bio, Inc. 3.07
    MIRM D Mirum Pharmaceuticals, Inc. 3.41
    BFRG D Bullfrog AI Holdings, Inc 4.49
    GYRE F Gyre Therapeutics, Inc. -3.75
    ALGS F Aligos Therapeutics, Inc. -0.35
    TARA F ArTara Therapeutics, Inc. -0.56
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Medicine Biopharmaceutical Alcohol Hepatology Clinical Medicine Coronavirus Drug Development Fatty Liver Disease IBD 50 Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Acid Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Deficiency

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 12.59
    IBBQ D Invesco Nasdaq Biotechnology ETF 12.39
    IBB D iShares Nasdaq Biotechnology Index Fund 12.01
    GNOM D Global X Genomics & Biotechnology ETF 9.15
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.01
    View all Liver Disease ETFs...
    Compare ETFs
    Compare BBH to BIS Compare BBH to IBB Compare IBBQ to IBB

        Liver Disease Stocks Recent News

        Date Stock Title
        Oct 2 GILD Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
        Oct 2 ALNY Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
        Oct 2 GILD Gilead signs deals with six drugmakers for generic lenacapavir
        Oct 2 GILD Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
        Oct 1 GILD Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
        Oct 1 GILD $1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
        Oct 1 ALNY Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
        Oct 1 ALNY Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
        Oct 1 GILD Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It
        Sep 30 GALT Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference
        Sep 30 ALGS Aligos Therapeutics to Present at Investor Conferences in October
        Sep 29 ALNY Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
        Sep 26 BLTE Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
        Sep 26 ALNY Alnylam to Webcast TTR Investor Day
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Medicine Biopharmaceutical Alcohol Hepatology Clinical Medicine Coronavirus Drug Development Fatty Liver Disease IBD 50 Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Acid Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Deficiency
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags